ORIGINAL PAPER
Reliability, validity, and reference norms of one-minute walk test in assessing cardiopulmonary functional capacity in healthy young adults: a pilot study
More details
Hide details
1
Department of Physiotherapy, State Hospital, Ifo, Nigeria
2
Department of Pediatric and Neonatal Physiotherapy, Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, Maharishi Markandeshwar (Deemed to be University), Mullana, India
Submission date: 2020-04-01
Acceptance date: 2020-10-28
Publication date: 2022-05-31
Physiother Quart. 2022;30(2):59-63
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Although the 6-minute walk test (6MWT) and 2-minute walk test (2MWT) are widely accepted tools for analysing functional capacity, in most clinical settings and populations, they may not be possible to apply owing to time and space constraints. Hence, an alternative walk test, one-minute walk test (1MWT), was introduced. There is, however, a lack of evidence on its reference norms, reliability, and validity. Thus, we aimed to estimate the reference norms, reliability, and validity of 1MWT among healthy young adults.
Methods:
A sample of 86 healthy adults aged 18–25 years were recruited by the simple random sampling technique for the normative study, and 14 participants for the validity and reliability study. They were asked to perform 1MWT and 6MWT in accordance with the American Thoracic Society guidelines. 1MWT was performed twice by each participant, with a minimum of 2 days to estimate test-retest reliability. The concurrent validity of 1MWT was established with 6MWT.
Results:
The reference norm of 1MWT with mean and 95% confidence interval is 74.3 (72.1–76.6) m. The test-retest reliability of 1MWT was estimated as an interclass correlation coefficient of 0.76 (0.60–0.86) with Cronbach’s alpha of 0.76. A good degree of concurrent validity exists between 1MWT and 6MWT, with Spearman’s = 0.79 (p < 0.001).
Conclusions:
1MWT has a good test-retest reliability and a good degree of concurrent validity with 6MWT. The reference norms of 1MWT have also been established.
REFERENCES (37)
1.
Stein R, Maia CP, Silveira AD, Chiappa GR, Myers J, Ribeiro JP. Inspiratory muscle strength as a determinant of functional capacity early after coronary artery bypass graft surgery. Arch Phys Med Rehabil. 2009;90(10):1685–1691; doi: 10.1016/j.apmr.2009.05.010.
2.
Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed). 1982;284(6329):1607–1608; doi: 10.1136/bmj.284.6329.1607.
3.
Kosak M, Smith T. Comparison of the 2-, 6-, and 12-minute walk tests in patients with stroke. J Rehabil Res Dev. 2005;42(1):103–107; doi: 10.1682/jrrd.2003.11.0171.
4.
Connelly DM, Thomas BK, Cliffe SJ, Perry WM, Smith RE. Clinical utility of the 2-minute walk test for older adults living in long-term care. Physiother Can. 2009;61(2):78–87; doi: 10.3138/physio.61.2.78.
5.
Balke B. A simple field test for the assessment of physical fitness. Rep Civ Aeromed Res Inst US. 1963;1–8.
6.
Cooper KH. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA. 1968;203(3):201–204; doi: 10.1001/jama.1968.03140030033008.
7.
McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J. 1976;1(6013):822–823; doi: 10.1136/bmj.1.6013.822.
8.
Brooks D, Davis AM, Naglie G. The feasibility of six-minute and two-minute walk tests in in-patient geriatric rehabilitation. Can J Aging. 2007;26(2):159–162; doi: 10.3138/cja.26.2.009.
9.
Guyatt GH, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med. 1989;83(4):293–297; doi: 10.1016/s0954-6111(89)80199-4.
10.
Mancuso CA, Choi TN, Westermann H, Briggs WM, Wenderoth S, Charlson ME. Measuring physical activity in asthma patients: two-minute walk test, repeated chair rise test, and self-reported energy expenditure. J Asthma. 2007;44(4):333–340; doi: 10.1080/02770900701344413.
11.
Upton CJ, Tyrrell JC, Hiller EJ. Two minute walking distance in cystic fibrosis. Arch Dis Child. 1988;63(12):1444–1448; doi: 10.1136/adc.63.12.1444.
12.
Brooks D, Parsons J, Tran D, Jeng B, Gorczyca B, Newton J, et al. The two-minute walk test as a measure of functional capacity in cardiac surgery patients. Arch Phys Med Rehabil. 2004;85(9):1525–1530; doi: 10.1016/j.apmr.2004.01.023.
13.
Resnik L, Borgia M. Reliability of outcome measures for people with lower-limb amputations: distinguishing true change from statistical error. Phys Ther. 2011;91(4):555–565; doi: 10.2522/ptj.20100287.
14.
Brooks D, Hunter JP, Parsons J, Livsey E, Quirt J, Devlin M. Reliability of the two-minute walk test in individuals with transtibial amputation. Arch Phys Med Rehabil. 2002;83(11):1562–1565; doi: 10.1053/apmr.2002.34600.
15.
Visser J, McCarthy I, Marks L, Davis RC. Is hip muscle strength the key to walking as a bilateral amputee, whatever the level of the amputations? Prosthet Orthot Int. 2011;35(4):451–458; doi: 10.1177/0309364611422268.
16.
Erjavec T, Presern-Strukelj M, Burger H. The diagnostic importance of exercise testing in developing appropriate rehabilitation programmes for patients following transfemoral amputation. Eur J Phys Rehabil Med. 2008;44(2):133–139.
17.
Broekmans T, Roelants M, Feys P, Alders G, Gijbels D, Hanssen I, et al. Effects of long-term resistance training and simultaneous electro-stimulation on muscle strength and functional mobility in multiple sclerosis. Mult Scler. 2011;17(4):468–477; doi: 10.1177/1352458510391339.
18.
Collett J, Dawes H, Meaney A, Sackley C, Barker K, Wade D, et al. Exercise for multiple sclerosis: a single-blind randomized trial comparing three exercise intensities. Mult Scler. 2011;17(5):594–603; doi: 10.1177/1352458510391836.
19.
White DK, Wagenaar RC, Ellis TD, Tickle-Degnen L. Changes in walking activity and endurance following rehabilitation for people with Parkinson disease. Arch Phys Med Rehabil. 2009;90(1):43–50; doi: 10.1016/j.apmr.2008.06.034.
20.
Ratchford JN, Shore W, Hammond ER, Rose JG, Rifkin R, Nie P, et al. A pilot study of functional electrical stimulation cycling in progressive multiple sclerosis. NeuroRehabilitation. 2010;27(2):121–128; doi: 10.3233/NRE-2010-0588.
21.
Sibley KM, Tang A, Patterson KK, Brooks D, McIlroy WE. Changes in spatiotemporal gait variables over time during a test of functional capacity after stroke. J Neuroeng Rehabil. 2009;6:27; doi: 10.1186/1743-0003-6-27.
22.
Mendelsohn ME, Overend TJ, Connelly DM, Petrella RJ. Improvement in aerobic fitness during rehabilitation after hip fracture. Arch Phys Med Rehabil. 2008;89(4):609–617; doi: 10.1016/j.apmr.2007.09.036.
23.
McDowell BC, Kerr C, Parkes J, Cosgrove A. Validity of a 1 minute walk test for children with cerebral palsy. Dev Med Child Neurol. 2005;47(11):744–748; doi: 10.1017/S0012162205001568.
24.
Bjornson KF, Moreau N, Bodkin AW. Short-burst interval treadmill training walking capacity and performance in cerebral palsy: a pilot study. Dev Neurorehabil. 2019;22(2):126–133; doi: 10.1080/17518423.2018.1462270.
25.
Martakis K, Stark C, Rehberg M, Semler O, Duran I, Schoenau E. One-minute walk test in children with cerebral palsy GMFCS level 1 and 2: reference values to identify therapeutic effects after rehabilitation. Dev Neurorehabil. 2020;23(4):201–209; doi: 10.1080/17518423.2019.1625981.
26.
Stewart A, Marfell-Jones M. International standards for anthropometric assessment. Lower Hutt: International Society for the Advancement of Kinanthropometry; 2011.
27.
American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117; doi: 10.1164/rccm.166/1/111.
28.
Chetta A, Zanini A, Pisi G, Aiello M, Tzani P, Neri M, et al. Reference values for the 6-min walk test in healthy subjects 20–50 years old. Respir Med. 2006;100(9):1573–1578; doi: 10.1016/j.rmed.2006.01.001.
29.
Iwama AM, Andrade GN, Shima P, Tanni SE, Godoy I, Dourado VZ. The six-minute walk test and body weight-walk distance product in healthy Brazilian subjects. Braz J Med Biol Res. 2009;42(11):1080–1085; doi: 10.1590/s0100-879x2009005000032.
30.
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287–291; doi: 10.1002/pst.185.
31.
Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing clinical research, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
32.
Van Lummel RC, Walgaard S, Hobert MA, Maetzler W, van Dieën JH, Galindo-Garre F, et al. Intra-rater, inter-rater and test-retest reliability of an instrumented Timed Up and Go (iTUG) test in patients with Parkinson’s disease. PLoS One. 2016;11(3):e0151881; doi: 10.1371/journal.pone.0151881.
33.
Bujang MA, Baharum N. A simplified guide to determination of sample size requirements for estimating the value of intraclass correlation coefficient: a review. Arch Orofac Sci. 2017;12(1):1–11.
34.
Ronan JT, Shafer AB. Concurrent validity of the five-minute pyramid test for VO2max estimation in healthy young adults. Hum Mov. 2019;20(4):41–45; doi: 10.5114/m.2019.85092.
35.
Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–160; doi: 10.1177/096228029900800204.
36.
Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420–428; doi: 10.1037/0033-2909.86.2.420.
37.
McDowell BC, Humphreys L, Kerr C, Stevenson M. Test-retest reliability of a 1-min walk test in children with bilateral spastic cerebral palsy (BSCP). Gait Posture. 2009;29(2):267–269; doi: 10.1016/j.gaitpost.2008.09.010.